<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IPNA Online</title>
	<atom:link href="http://www.ipna-online.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.ipna-online.org</link>
	<description>International Pediatric Nephrology Association</description>
	<lastBuildDate>Fri, 17 Feb 2012 20:08:58 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Women and Alport syndrome</title>
		<link>http://www.ipna-online.org/2012/01/women-and-alport-syndrome/</link>
		<comments>http://www.ipna-online.org/2012/01/women-and-alport-syndrome/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 17:23:49 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Glomerular Disorders]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1769</guid>
		<description><![CDATA[





The percentage of Alport syndrome inherited in an X-linked manner is:a. 100%b. 80%c. 50%d. 20%Heterozygous XLAS females can present with:a. Normal urinalysisb. Microscopic hematuriac. Proteinuriad. Sensorineural hearing losse. All of the aboveThe following has been shown to influence disease outcome in XLAS heterozygous femalesa.  X inactivation b. Ethnicityc. ACE inhibitiond. Pregnancye. GenotypeWhich of the [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-138">
<div class='question' id='question-1'><div class='question-content'>The percentage of Alport syndrome inherited in an X-linked manner is:</div><br /><input type='hidden' name='question_id[]' value='826' /><input type='radio' name='answer-826' id='answer-id-5972' class='answer' value='5972' /><label for='answer-id-5972'>a. 100%</label><br /><input type='radio' name='answer-826' id='answer-id-5973' class='answer' value='5973' /><label for='answer-id-5973'>b. 80%</label><br /><input type='radio' name='answer-826' id='answer-id-5974' class='answer' value='5974' /><label for='answer-id-5974'>c. 50%</label><br /><input type='radio' name='answer-826' id='answer-id-5975' class='answer' value='5975' /><label for='answer-id-5975'>d. 20%</label><br /></div><div class='question' id='question-2'><div class='question-content'>Heterozygous XLAS females can present with:</div><br /><input type='hidden' name='question_id[]' value='827' /><input type='radio' name='answer-827' id='answer-id-5980' class='answer' value='5980' /><label for='answer-id-5980'>a. Normal urinalysis</label><br /><input type='radio' name='answer-827' id='answer-id-5981' class='answer' value='5981' /><label for='answer-id-5981'>b. Microscopic hematuria</label><br /><input type='radio' name='answer-827' id='answer-id-5982' class='answer' value='5982' /><label for='answer-id-5982'>c. Proteinuria</label><br /><input type='radio' name='answer-827' id='answer-id-5983' class='answer' value='5983' /><label for='answer-id-5983'>d. Sensorineural hearing loss</label><br /><input type='radio' name='answer-827' id='answer-id-5984' class='answer' value='5984' /><label for='answer-id-5984'>e. All of the above</label><br /></div><div class='question' id='question-3'><div class='question-content'>The following has been shown to influence disease outcome in XLAS heterozygous females</div><br /><input type='hidden' name='question_id[]' value='828' /><input type='radio' name='answer-828' id='answer-id-5989' class='answer' value='5989' /><label for='answer-id-5989'>a.  X inactivation </label><br /><input type='radio' name='answer-828' id='answer-id-5990' class='answer' value='5990' /><label for='answer-id-5990'>b. Ethnicity</label><br /><input type='radio' name='answer-828' id='answer-id-5991' class='answer' value='5991' /><label for='answer-id-5991'>c. ACE inhibition</label><br /><input type='radio' name='answer-828' id='answer-id-5992' class='answer' value='5992' /><label for='answer-id-5992'>d. Pregnancy</label><br /><input type='radio' name='answer-828' id='answer-id-5993' class='answer' value='5993' /><label for='answer-id-5993'>e. Genotype</label><br /></div><div class='question' id='question-4'><div class='question-content'>Which of the following are risk factors for renal disease progression in XLAS heterozygous females?</div><br /><input type='hidden' name='question_id[]' value='829' /><input type='radio' name='answer-829' id='answer-id-5998' class='answer' value='5998' /><label for='answer-id-5998'>a. Microscopic hematuria</label><br /><input type='radio' name='answer-829' id='answer-id-5999' class='answer' value='5999' /><label for='answer-id-5999'>b. Proteinuria</label><br /><input type='radio' name='answer-829' id='answer-id-6000' class='answer' value='6000' /><label for='answer-id-6000'>c. Use of hormone replacement therapy</label><br /><input type='radio' name='answer-829' id='answer-id-6001' class='answer' value='6001' /><label for='answer-id-6001'>d. Hearing loss</label><br /><input type='radio' name='answer-829' id='answer-id-6002' class='answer' value='6002' /><label for='answer-id-6002'>e. B and D</label><br /><input type='radio' name='answer-829' id='answer-id-6003' class='answer' value='6003' /><label for='answer-id-6003'>f. B and C</label><br /></div><div class='question' id='question-5'><div class='question-content'>X inactivation patterns in this tissue can predict X inactivation patterns in the kidney</div><br /><input type='hidden' name='question_id[]' value='830' /><input type='radio' name='answer-830' id='answer-id-6004' class='answer' value='6004' /><label for='answer-id-6004'>a. Blood lymphocytes</label><br /><input type='radio' name='answer-830' id='answer-id-6005' class='answer' value='6005' /><label for='answer-id-6005'>b. Skin</label><br /><input type='radio' name='answer-830' id='answer-id-6006' class='answer' value='6006' /><label for='answer-id-6006'>c. Urinary epithelium</label><br /><input type='radio' name='answer-830' id='answer-id-6007' class='answer' value='6007' /><label for='answer-id-6007'>d. None of the above</label><br /></div><div class='question' id='question-6'><div class='question-content'>Heterozygous XLAS females should be considered as kidney donors if they meet all of the following criteria except:</div><br /><input type='hidden' name='question_id[]' value='831' /><input type='radio' name='answer-831' id='answer-id-6008' class='answer' value='6008' /><label for='answer-id-6008'>a. Presence of microscopic hematuria</label><br /><input type='radio' name='answer-831' id='answer-id-6009' class='answer' value='6009' /><label for='answer-id-6009'>b. Presence of proteinuria</label><br /><input type='radio' name='answer-831' id='answer-id-6010' class='answer' value='6010' /><label for='answer-id-6010'>c. Absence of sensorineural hearing loss</label><br /><input type='radio' name='answer-831' id='answer-id-6011' class='answer' value='6011' /><label for='answer-id-6011'>d. Absence of hypertension 
 

</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="138" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/women-and-alport-syndrome/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist</title>
		<link>http://www.ipna-online.org/2012/01/hepcidin-in-anemia-of-chronic-kidney-disease-review-for-the-pediatric-nephrologist/</link>
		<comments>http://www.ipna-online.org/2012/01/hepcidin-in-anemia-of-chronic-kidney-disease-review-for-the-pediatric-nephrologist/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 17:07:26 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Anemia]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1766</guid>
		<description><![CDATA[


Elevated serum ferritin levels can be observed in the setting of:a. Total body iron overloadb. Acute inflammationc. Reticuloendothelial blockaded. All of the aboveHepcidin gene transcription is down-regulated by:a. Inflammatory conditionsb. Enteral iron ingestionc. Tissue hypoxiad. Intravenous iron administrationFerroportin channels are found in the cell membranes of which cell types?a. Macrophages and enterocytesb. Macrophages and RBCc. [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-137">
<div class='question' id='question-1'><div class='question-content'>Elevated serum ferritin levels can be observed in the setting of:</div><br /><input type='hidden' name='question_id[]' value='821' /><input type='radio' name='answer-821' id='answer-id-5952' class='answer' value='5952' /><label for='answer-id-5952'>a. Total body iron overload</label><br /><input type='radio' name='answer-821' id='answer-id-5953' class='answer' value='5953' /><label for='answer-id-5953'>b. Acute inflammation</label><br /><input type='radio' name='answer-821' id='answer-id-5954' class='answer' value='5954' /><label for='answer-id-5954'>c. Reticuloendothelial blockade</label><br /><input type='radio' name='answer-821' id='answer-id-5955' class='answer' value='5955' /><label for='answer-id-5955'>d. All of the above</label><br /></div><div class='question' id='question-2'><div class='question-content'>Hepcidin gene transcription is down-regulated by:</div><br /><input type='hidden' name='question_id[]' value='822' /><input type='radio' name='answer-822' id='answer-id-5956' class='answer' value='5956' /><label for='answer-id-5956'>a. Inflammatory conditions</label><br /><input type='radio' name='answer-822' id='answer-id-5957' class='answer' value='5957' /><label for='answer-id-5957'>b. Enteral iron ingestion</label><br /><input type='radio' name='answer-822' id='answer-id-5958' class='answer' value='5958' /><label for='answer-id-5958'>c. Tissue hypoxia</label><br /><input type='radio' name='answer-822' id='answer-id-5959' class='answer' value='5959' /><label for='answer-id-5959'>d. Intravenous iron administration</label><br /></div><div class='question' id='question-3'><div class='question-content'>Ferroportin channels are found in the cell membranes of which cell types?</div><br /><input type='hidden' name='question_id[]' value='823' /><input type='radio' name='answer-823' id='answer-id-5960' class='answer' value='5960' /><label for='answer-id-5960'>a. Macrophages and enterocytes</label><br /><input type='radio' name='answer-823' id='answer-id-5961' class='answer' value='5961' /><label for='answer-id-5961'>b. Macrophages and RBC</label><br /><input type='radio' name='answer-823' id='answer-id-5962' class='answer' value='5962' /><label for='answer-id-5962'>c. Enterocytes and RBC</label><br /><input type='radio' name='answer-823' id='answer-id-5963' class='answer' value='5963' /><label for='answer-id-5963'>d. Lymphocytes and macrophages</label><br /></div><div class='question' id='question-4'><div class='question-content'>Probable mechanisms for increased hepcidin levels in CKD include:</div><br /><input type='hidden' name='question_id[]' value='824' /><input type='radio' name='answer-824' id='answer-id-5964' class='answer' value='5964' /><label for='answer-id-5964'>a. Decreased renal clearance</label><br /><input type='radio' name='answer-824' id='answer-id-5965' class='answer' value='5965' /><label for='answer-id-5965'>b. Induction by inflammatory cytokines</label><br /><input type='radio' name='answer-824' id='answer-id-5966' class='answer' value='5966' /><label for='answer-id-5966'>c. Chronic iron therapy</label><br /><input type='radio' name='answer-824' id='answer-id-5967' class='answer' value='5967' /><label for='answer-id-5967'>d. All of the above</label><br /></div><div class='question' id='question-5'><div class='question-content'>Serum hepcidin levels have been shown to be modified by:</div><br /><input type='hidden' name='question_id[]' value='825' /><input type='radio' name='answer-825' id='answer-id-5968' class='answer' value='5968' /><label for='answer-id-5968'>a. Nonsteroidal anti-inflammatory drugs</label><br /><input type='radio' name='answer-825' id='answer-id-5969' class='answer' value='5969' /><label for='answer-id-5969'>b.  Dialysis </label><br /><input type='radio' name='answer-825' id='answer-id-5970' class='answer' value='5970' /><label for='answer-id-5970'>c. Hemapheresis</label><br /><input type='radio' name='answer-825' id='answer-id-5971' class='answer' value='5971' /><label for='answer-id-5971'>d. ACE inhibitors 
 

</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="137" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/hepcidin-in-anemia-of-chronic-kidney-disease-review-for-the-pediatric-nephrologist/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CKD-MBD after kidney transplantation</title>
		<link>http://www.ipna-online.org/2012/01/ckd-mbd-after-kidney-transplantation/</link>
		<comments>http://www.ipna-online.org/2012/01/ckd-mbd-after-kidney-transplantation/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 16:51:00 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Bone]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1762</guid>
		<description><![CDATA[


In post-transplantation renal osteodystrophya. PTH levels correlate closely with bone turnoverb. bone turnover returns to the normal range in all patientsc. defects in skeletal mineralization are commond. adynamic bone disease is rareIn pediatric renal transplant recipients, bone densitya. is best assessed using DXA with age-matched controlsb. is best assessed using DXA with height-matched controlsc. is [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-136">
<div class='question' id='question-1'><div class='question-content'>In post-transplantation renal osteodystrophy</div><br /><input type='hidden' name='question_id[]' value='816' /><input type='radio' name='answer-816' id='answer-id-5932' class='answer' value='5932' /><label for='answer-id-5932'>a. PTH levels correlate closely with bone turnover</label><br /><input type='radio' name='answer-816' id='answer-id-5933' class='answer' value='5933' /><label for='answer-id-5933'>b. bone turnover returns to the normal range in all patients</label><br /><input type='radio' name='answer-816' id='answer-id-5934' class='answer' value='5934' /><label for='answer-id-5934'>c. defects in skeletal mineralization are common</label><br /><input type='radio' name='answer-816' id='answer-id-5935' class='answer' value='5935' /><label for='answer-id-5935'>d. adynamic bone disease is rare</label><br /></div><div class='question' id='question-2'><div class='question-content'>In pediatric renal transplant recipients, bone density</div><br /><input type='hidden' name='question_id[]' value='817' /><input type='radio' name='answer-817' id='answer-id-5936' class='answer' value='5936' /><label for='answer-id-5936'>a. is best assessed using DXA with age-matched controls</label><br /><input type='radio' name='answer-817' id='answer-id-5937' class='answer' value='5937' /><label for='answer-id-5937'>b. is best assessed using DXA with height-matched controls</label><br /><input type='radio' name='answer-817' id='answer-id-5938' class='answer' value='5938' /><label for='answer-id-5938'>c. is best assessed using DXA with gender-matched controls</label><br /><input type='radio' name='answer-817' id='answer-id-5939' class='answer' value='5939' /><label for='answer-id-5939'>d. cannot reliably be assessed by DXA</label><br /></div><div class='question' id='question-3'><div class='question-content'>Post renal transplantation, cardiovascular disease</div><br /><input type='hidden' name='question_id[]' value='818' /><input type='radio' name='answer-818' id='answer-id-5940' class='answer' value='5940' /><label for='answer-id-5940'>a. resolves within the first 2 years</label><br /><input type='radio' name='answer-818' id='answer-id-5941' class='answer' value='5941' /><label for='answer-id-5941'>b. improves (in adults) with the use of lipid-lowering agents</label><br /><input type='radio' name='answer-818' id='answer-id-5942' class='answer' value='5942' /><label for='answer-id-5942'>c. is unrelated to traditional risk factors, such as hypertension</label><br /><input type='radio' name='answer-818' id='answer-id-5943' class='answer' value='5943' /><label for='answer-id-5943'>d. is minimal in children</label><br /></div><div class='question' id='question-4'><div class='question-content'>The leading cause of death in children post renal transplantation is</div><br /><input type='hidden' name='question_id[]' value='819' /><input type='radio' name='answer-819' id='answer-id-5944' class='answer' value='5944' /><label for='answer-id-5944'>a. cardiovascular disease</label><br /><input type='radio' name='answer-819' id='answer-id-5945' class='answer' value='5945' /><label for='answer-id-5945'>b. cancer</label><br /><input type='radio' name='answer-819' id='answer-id-5946' class='answer' value='5946' /><label for='answer-id-5946'>c. infection</label><br /><input type='radio' name='answer-819' id='answer-id-5947' class='answer' value='5947' /><label for='answer-id-5947'>d. trauma</label><br /></div><div class='question' id='question-5'><div class='question-content'>After renal transplantation growth</div><br /><input type='hidden' name='question_id[]' value='820' /><input type='radio' name='answer-820' id='answer-id-5948' class='answer' value='5948' /><label for='answer-id-5948'>a. improves equally in all age groups, from infancy to adolescence</label><br /><input type='radio' name='answer-820' id='answer-id-5949' class='answer' value='5949' /><label for='answer-id-5949'>b.  improves with steroid-avoidant and steroid-minimizing immunosuppressant protocols </label><br /><input type='radio' name='answer-820' id='answer-id-5950' class='answer' value='5950' /><label for='answer-id-5950'>c. does not respond to growth hormone</label><br /><input type='radio' name='answer-820' id='answer-id-5951' class='answer' value='5951' /><label for='answer-id-5951'>d. is no longer a clinical problem 
 

</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="136" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/ckd-mbd-after-kidney-transplantation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Claudins in renal physiology and disease</title>
		<link>http://www.ipna-online.org/2012/01/claudins-in-renal-physiology-and-disease/</link>
		<comments>http://www.ipna-online.org/2012/01/claudins-in-renal-physiology-and-disease/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 16:40:09 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Fluid and Electrolytes]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1760</guid>
		<description><![CDATA[


Which of the following best describes paracellular permeability and transport in the late proximal tubule?a. The proximal tubule has a high transepithelial resistance and acts as a barrier to small ionsb. NaCl is reabsorbed paracellularly, driven by the Cl concentration gradientc. Organic anions are secreted across the paracellular pathwayd. Water is predominantly reabsorbed via the [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-135">
<div class='question' id='question-1'><div class='question-content'>Which of the following best describes paracellular permeability and transport in the late proximal tubule?</div><br /><input type='hidden' name='question_id[]' value='810' /><input type='radio' name='answer-810' id='answer-id-5882' class='answer' value='5882' /><label for='answer-id-5882'>a. The proximal tubule has a high transepithelial resistance and acts as a barrier to small ions</label><br /><input type='radio' name='answer-810' id='answer-id-5883' class='answer' value='5883' /><label for='answer-id-5883'>b. NaCl is reabsorbed paracellularly, driven by the Cl concentration gradient</label><br /><input type='radio' name='answer-810' id='answer-id-5884' class='answer' value='5884' /><label for='answer-id-5884'>c. Organic anions are secreted across the paracellular pathway</label><br /><input type='radio' name='answer-810' id='answer-id-5885' class='answer' value='5885' /><label for='answer-id-5885'>d. Water is predominantly reabsorbed via the paracellular pathway, driven by the osmotic gradient</label><br /><input type='radio' name='answer-810' id='answer-id-5886' class='answer' value='5886' /><label for='answer-id-5886'>e. The proximal tubule is selectively permeable to bicarbonate which is reabsorbed paracellularly</label><br /></div><div class='question' id='question-2'><div class='question-content'>Which domain of the claudin protein forms the lining of the paracellular pore?</div><br /><input type='hidden' name='question_id[]' value='811' /><input type='radio' name='answer-811' id='answer-id-5891' class='answer' value='5891' /><label for='answer-id-5891'>a. Amino terminal</label><br /><input type='radio' name='answer-811' id='answer-id-5892' class='answer' value='5892' /><label for='answer-id-5892'>b. Carboxy terminal</label><br /><input type='radio' name='answer-811' id='answer-id-5893' class='answer' value='5893' /><label for='answer-id-5893'>c. 1st transmembrane domain</label><br /><input type='radio' name='answer-811' id='answer-id-5894' class='answer' value='5894' /><label for='answer-id-5894'>d. 1st extracellular domain</label><br /><input type='radio' name='answer-811' id='answer-id-5895' class='answer' value='5895' /><label for='answer-id-5895'>e. Cytosolic loop between 2nd and 3rd transmembrane domain</label><br /></div><div class='question' id='question-3'><div class='question-content'>It has been shown that D65 (aspartate residue at position 65) in claudin-2 is a cation-binding site that is responsible for its cation-selectivity. Which of the following mutation of claudin-2 would be most likely to turn claudin-2 from a cation-selective pore to an anion-selective pore?</div><br /><input type='hidden' name='question_id[]' value='812' /><input type='radio' name='answer-812' id='answer-id-5900' class='answer' value='5900' /><label for='answer-id-5900'>a. D65K (mutation to lysine)</label><br /><input type='radio' name='answer-812' id='answer-id-5901' class='answer' value='5901' /><label for='answer-id-5901'>b.  D65C (mutation to cysteine) </label><br /><input type='radio' name='answer-812' id='answer-id-5902' class='answer' value='5902' /><label for='answer-id-5902'>c. D65A (mutation to alanine)</label><br /><input type='radio' name='answer-812' id='answer-id-5903' class='answer' value='5903' /><label for='answer-id-5903'>d. D65S (mutation to serine)</label><br /><input type='radio' name='answer-812' id='answer-id-5904' class='answer' value='5904' /><label for='answer-id-5904'>e. D65L (mutation to leucine)</label><br /></div><div class='question' id='question-4'><div class='question-content'>All of the following are clinical features of familial hypomagnesemic hypercalciuria with nephrocalcinosis (FHHNC), EXCEPT:</div><br /><input type='hidden' name='question_id[]' value='813' /><input type='radio' name='answer-813' id='answer-id-5909' class='answer' value='5909' /><label for='answer-id-5909'>a. Increased fractional excretion of Mg</label><br /><input type='radio' name='answer-813' id='answer-id-5910' class='answer' value='5910' /><label for='answer-id-5910'>b. Rickets</label><br /><input type='radio' name='answer-813' id='answer-id-5911' class='answer' value='5911' /><label for='answer-id-5911'>c. Decreased GFR</label><br /><input type='radio' name='answer-813' id='answer-id-5912' class='answer' value='5912' /><label for='answer-id-5912'>d. Ocular abnormalities</label><br /><input type='radio' name='answer-813' id='answer-id-5913' class='answer' value='5913' /><label for='answer-id-5913'>e. Deafness</label><br /></div><div class='question' id='question-5'><div class='question-content'>Which of the following treatments ameliorate the urinary Mg and Ca wasting in FHHNC?</div><br /><input type='hidden' name='question_id[]' value='814' /><input type='radio' name='answer-814' id='answer-id-5918' class='answer' value='5918' /><label for='answer-id-5918'>a. Thiazide diuretics</label><br /><input type='radio' name='answer-814' id='answer-id-5919' class='answer' value='5919' /><label for='answer-id-5919'>b. Magnesium supplementation</label><br /><input type='radio' name='answer-814' id='answer-id-5920' class='answer' value='5920' /><label for='answer-id-5920'>c.  Amiloride </label><br /><input type='radio' name='answer-814' id='answer-id-5921' class='answer' value='5921' /><label for='answer-id-5921'>d. Oral phosphate binders</label><br /><input type='radio' name='answer-814' id='answer-id-5922' class='answer' value='5922' /><label for='answer-id-5922'>e. Kidney transplantation</label><br /></div><div class='question' id='question-6'><div class='question-content'>Which of the following claudins are selectively expressed in the neonatal kidney but not in adult kidney?</div><br /><input type='hidden' name='question_id[]' value='815' /><input type='radio' name='answer-815' id='answer-id-5927' class='answer' value='5927' /><label for='answer-id-5927'>a. Claudin-2</label><br /><input type='radio' name='answer-815' id='answer-id-5928' class='answer' value='5928' /><label for='answer-id-5928'>b. Claudin-7</label><br /><input type='radio' name='answer-815' id='answer-id-5929' class='answer' value='5929' /><label for='answer-id-5929'>c. Claudin-9</label><br /><input type='radio' name='answer-815' id='answer-id-5930' class='answer' value='5930' /><label for='answer-id-5930'>d. Claudin-16</label><br /><input type='radio' name='answer-815' id='answer-id-5931' class='answer' value='5931' /><label for='answer-id-5931'>e. Claudin-19</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="135" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/claudins-in-renal-physiology-and-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Managing urinary tract infections</title>
		<link>http://www.ipna-online.org/2012/01/managing-urinary-tract-infections/</link>
		<comments>http://www.ipna-online.org/2012/01/managing-urinary-tract-infections/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 16:18:48 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Urinary Tract Disorders]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1756</guid>
		<description><![CDATA[


Which one of the following statements regarding UTI diagnosis is true?a. Clean-catch urine sample can be used in all childrenb. Uretheral catheterization or suprapubic aspiration should be performed in infants and newbornc. Uretheral catheterization has a lower likelihood of contamination compared with suprapubic aspirationd. Periuretheral adhesive bag can be used in boys but not girls [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-134">
<div class='question' id='question-1'><div class='question-content'>Which one of the following statements regarding UTI diagnosis is true?</div><br /><input type='hidden' name='question_id[]' value='806' /><input type='radio' name='answer-806' id='answer-id-5846' class='answer' value='5846' /><label for='answer-id-5846'>a. Clean-catch urine sample can be used in all children</label><br /><input type='radio' name='answer-806' id='answer-id-5847' class='answer' value='5847' /><label for='answer-id-5847'>b. Uretheral catheterization or suprapubic aspiration should be performed in infants and newborn</label><br /><input type='radio' name='answer-806' id='answer-id-5848' class='answer' value='5848' /><label for='answer-id-5848'>c. Uretheral catheterization has a lower likelihood of contamination compared with suprapubic aspiration</label><br /><input type='radio' name='answer-806' id='answer-id-5849' class='answer' value='5849' /><label for='answer-id-5849'>d. Periuretheral adhesive bag can be used in boys but not girls because of contamination risk</label><br /><input type='radio' name='answer-806' id='answer-id-5850' class='answer' value='5850' /><label for='answer-id-5850'>e. Any bacterial growth from a catheterized urine sample is considered significant 

</label><br /></div><div class='question' id='question-2'><div class='question-content'>Of the following, which one is the most specific test for UTI by dipstick?</div><br /><input type='hidden' name='question_id[]' value='807' /><input type='radio' name='answer-807' id='answer-id-5855' class='answer' value='5855' /><label for='answer-id-5855'>a. LE alone</label><br /><input type='radio' name='answer-807' id='answer-id-5856' class='answer' value='5856' /><label for='answer-id-5856'>b. Nitrite alone</label><br /><input type='radio' name='answer-807' id='answer-id-5857' class='answer' value='5857' /><label for='answer-id-5857'>c. Protein and blood</label><br /><input type='radio' name='answer-807' id='answer-id-5858' class='answer' value='5858' /><label for='answer-id-5858'>d. LE and nitrite</label><br /><input type='radio' name='answer-807' id='answer-id-5859' class='answer' value='5859' /><label for='answer-id-5859'>e. Protein and LE 

</label><br /></div><div class='question' id='question-3'><div class='question-content'>Which one of the following characterizes asymptomatic bacteriuria?</div><br /><input type='hidden' name='question_id[]' value='808' /><input type='radio' name='answer-808' id='answer-id-5864' class='answer' value='5864' /><label for='answer-id-5864'>a. Pyuria is present</label><br /><input type='radio' name='answer-808' id='answer-id-5865' class='answer' value='5865' /><label for='answer-id-5865'>b. Most commonly caused by Pseudomonas Aeruginosa </label><br /><input type='radio' name='answer-808' id='answer-id-5866' class='answer' value='5866' /><label for='answer-id-5866'>c. Antibiotic treatment is indicated</label><br /><input type='radio' name='answer-808' id='answer-id-5867' class='answer' value='5867' /><label for='answer-id-5867'>d. Can be a normal finding in children with neurogenic bladder</label><br /><input type='radio' name='answer-808' id='answer-id-5868' class='answer' value='5868' /><label for='answer-id-5868'>e. Increased risk of scarring if antibiotic prophylaxis is not used 

</label><br /></div><div class='question' id='question-4'><div class='question-content'>Which of the following tests is the current gold standard for diagnosing renal scarring?</div><br /><input type='hidden' name='question_id[]' value='809' /><input type='radio' name='answer-809' id='answer-id-5873' class='answer' value='5873' /><label for='answer-id-5873'>a. Ultrasound examination</label><br /><input type='radio' name='answer-809' id='answer-id-5874' class='answer' value='5874' /><label for='answer-id-5874'>b. Intravenous pyelography</label><br /><input type='radio' name='answer-809' id='answer-id-5875' class='answer' value='5875' /><label for='answer-id-5875'>c. DMSA renal scan</label><br /><input type='radio' name='answer-809' id='answer-id-5876' class='answer' value='5876' /><label for='answer-id-5876'>d. CT scan</label><br /><input type='radio' name='answer-809' id='answer-id-5877' class='answer' value='5877' /><label for='answer-id-5877'>e. Radionuclear cystography (RNC) 

</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="134" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/managing-urinary-tract-infections/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Microalbuminuria: causes and implications</title>
		<link>http://www.ipna-online.org/2012/01/microalbuminuria-causes-and-implications/</link>
		<comments>http://www.ipna-online.org/2012/01/microalbuminuria-causes-and-implications/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 16:00:44 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Chronic Kidney Disease]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1753</guid>
		<description><![CDATA[


In estimating microalbuminuria, the following statment is true:a. early morning spot urine for albumin creatinine ratio is the bestb. 24-h urine collection should always be done when possiblec. urine protein creatinine ratio is as reliable as the urine albumin creatinine ratiod. the standard urine dip stick in the clinic is equally reliableThe estimates of prevalence [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-133">
<div class='question' id='question-1'><div class='question-content'>In estimating microalbuminuria, the following statment is true:</div><br /><input type='hidden' name='question_id[]' value='801' /><input type='radio' name='answer-801' id='answer-id-5822' class='answer' value='5822' /><label for='answer-id-5822'>a. early morning spot urine for albumin creatinine ratio is the best</label><br /><input type='radio' name='answer-801' id='answer-id-5823' class='answer' value='5823' /><label for='answer-id-5823'>b. 24-h urine collection should always be done when possible</label><br /><input type='radio' name='answer-801' id='answer-id-5824' class='answer' value='5824' /><label for='answer-id-5824'>c. urine protein creatinine ratio is as reliable as the urine albumin creatinine ratio</label><br /><input type='radio' name='answer-801' id='answer-id-5825' class='answer' value='5825' /><label for='answer-id-5825'>d. the standard urine dip stick in the clinic is equally reliable</label><br /></div><div class='question' id='question-2'><div class='question-content'><div>The estimates of prevalence of microalbuminuria in children are:</div></div><br /><input type='hidden' name='question_id[]' value='802' /><input type='radio' name='answer-802' id='answer-id-5826' class='answer' value='5826' /><label for='answer-id-5826'>a. higher compared to young adults</label><br /><input type='radio' name='answer-802' id='answer-id-5827' class='answer' value='5827' /><label for='answer-id-5827'>b. higher in girls and children from an ethnic background</label><br /><input type='radio' name='answer-802' id='answer-id-5828' class='answer' value='5828' /><label for='answer-id-5828'>c. are likely confounded by the effects of orthostatic proteinuria</label><br /><input type='radio' name='answer-802' id='answer-id-5829' class='answer' value='5829' /><label for='answer-id-5829'>d. all of the above</label><br /></div><div class='question' id='question-3'><div class='question-content'><div>Postural or orthostatic proteinuria</div></div><br /><input type='hidden' name='question_id[]' value='803' /><input type='radio' name='answer-803' id='answer-id-5830' class='answer' value='5830' /><label for='answer-id-5830'>a. is not a benign condition and indicates progressive kidney disease</label><br /><input type='radio' name='answer-803' id='answer-id-5831' class='answer' value='5831' /><label for='answer-id-5831'>b. more common in obese girls</label><br /><input type='radio' name='answer-803' id='answer-id-5832' class='answer' value='5832' /><label for='answer-id-5832'>c. mostly associated with ‘nutcracker syndrome’</label><br /><input type='radio' name='answer-803' id='answer-id-5833' class='answer' value='5833' /><label for='answer-id-5833'>d. should be managed with ACE inhibitors</label><br /></div><div class='question' id='question-4'><div class='question-content'><div>Generalized endothelial dysfunction is</div></div><br /><input type='hidden' name='question_id[]' value='804' /><input type='radio' name='answer-804' id='answer-id-5834' class='answer' value='5834' /><label for='answer-id-5834'>a. rarely seen in children</label><br /><input type='radio' name='answer-804' id='answer-id-5835' class='answer' value='5835' /><label for='answer-id-5835'>b. usually precedes the onset of microalbuminuria</label><br /><input type='radio' name='answer-804' id='answer-id-5836' class='answer' value='5836' /><label for='answer-id-5836'>c. is reversed in early adult life</label><br /><input type='radio' name='answer-804' id='answer-id-5837' class='answer' value='5837' /><label for='answer-id-5837'>d. is exclusively seen in diabetic children</label><br /></div><div class='question' id='question-5'><div class='question-content'><div>The glomerular endothelial glycocalyx layer</div></div><br /><input type='hidden' name='question_id[]' value='805' /><input type='radio' name='answer-805' id='answer-id-5838' class='answer' value='5838' /><label for='answer-id-5838'>a. is a dynamic layer that is produced by glomerular endothelial cells</label><br /><input type='radio' name='answer-805' id='answer-id-5839' class='answer' value='5839' /><label for='answer-id-5839'>b. is vulnerable to damage in systemic diseases</label><br /><input type='radio' name='answer-805' id='answer-id-5840' class='answer' value='5840' /><label for='answer-id-5840'>c. is an important contributor to resistance to protein permeability</label><br /><input type='radio' name='answer-805' id='answer-id-5841' class='answer' value='5841' /><label for='answer-id-5841'>d. all of the above</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="133" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/microalbuminuria-causes-and-implications/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Saudi International Conference of Nephrology &amp; Transplantation</title>
		<link>http://www.ipna-online.org/2012/01/saudi-international-conference-of-nephrology-transplantation/</link>
		<comments>http://www.ipna-online.org/2012/01/saudi-international-conference-of-nephrology-transplantation/#comments</comments>
		<pubDate>Wed, 04 Jan 2012 19:24:54 +0000</pubDate>
		<dc:creator>rdelacruz</dc:creator>
				<category><![CDATA[Congresses]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1744</guid>
		<description><![CDATA[[ February 19, 2012 to February 22, 2012. ] Location: King Fahd Cultural Center, Riyadh-Kingdom of Saudi Arabia 

For more information: http://www.ssnconference.org]]></description>
			<content:encoded><![CDATA[<table class="ec3_schedule"><tr><td class="ec3_start">February 19, 2012</td><td class="ec3_to">to</td><td class="ec3_end">February 22, 2012</td></tr></table><p><strong>Location: </strong>King Fahd Cultural Center, Riyadh-Kingdom of Saudi Arabia </p>
<p><strong>For more information: <a href="http://www.ssnconference.org" target="_blank">http://www.ssnconference.org</a></strong></p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2012/01/saudi-international-conference-of-nephrology-transplantation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects</title>
		<link>http://www.ipna-online.org/2011/11/bartter-and-gitelman-like-syndromes-salt-losing-tubulopathies-with-loop-or-dct-defects/</link>
		<comments>http://www.ipna-online.org/2011/11/bartter-and-gitelman-like-syndromes-salt-losing-tubulopathies-with-loop-or-dct-defects/#comments</comments>
		<pubDate>Thu, 10 Nov 2011 20:46:01 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Tubular Disorders]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1713</guid>
		<description><![CDATA[


The pregnancy of a 28-year-old woman with one previous miscarriage is complicated by idiopathic polyhydramnios, which was first recognized by routine ultrasound at the end of the second trimester. After therapeutic amniocentesis (estimated amniotic fluid volume of 10 l) and rupture of membranes at 30 weeks of gestation, an acute Caesarean section was performed. The delivered male [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-132">
<div class='question' id='question-1'><div class='question-content'><div>The pregnancy of a 28-year-old woman with one previous miscarriage is complicated by idiopathic polyhydramnios, which was first recognized by routine ultrasound at the end of the second trimester. After therapeutic amniocentesis (estimated amniotic fluid volume of 10 l) and rupture of membranes at 30 weeks of gestation, an acute Caesarean section was performed. The delivered male infant was appropriate for gestational age and showed an uneventful postnatal adaptation, except for a mild respiratory distress syndrome requiring a positive end-expiratory pressure device. However, a few days later, he developed hyponatremia, hyperkalemia, hyposthenuria, hypercalciuria, and a weight loss from birthweight by &gt;15%. The diagnosis most likely is:</div></div><br /><input type='hidden' name='question_id[]' value='795' /><input type='radio' name='answer-795' id='answer-id-5782' class='answer' value='5782' /><label for='answer-id-5782'>a. Nephrogenic diabetes insipidus</label><br /><input type='radio' name='answer-795' id='answer-id-5783' class='answer' value='5783' /><label for='answer-id-5783'>b. Loop disorder with NKCC2 defect (BS type 1)</label><br /><input type='radio' name='answer-795' id='answer-id-5784' class='answer' value='5784' /><label for='answer-id-5784'>c. Loop disorder with ROMK defect (BS type II)</label><br /><input type='radio' name='answer-795' id='answer-id-5785' class='answer' value='5785' /><label for='answer-id-5785'>d. Combined loop and DCT disorder with barttin defect (BS type IV)</label><br /><input type='radio' name='answer-795' id='answer-id-5786' class='answer' value='5786' /><label for='answer-id-5786'>e. Combined loop and DCT disorder with a defect in ClC-Ka and ClC-Kb</label><br /></div><div class='question' id='question-2'><div class='question-content'>What is the most appropriate pharmacotherapeutic intervention in a patient with polyuric and hypercalciuric salt-losing tubulopathy associated with hyperaldosteronism?</div><br /><input type='hidden' name='question_id[]' value='796' /><input type='radio' name='answer-796' id='answer-id-5791' class='answer' value='5791' /><label for='answer-id-5791'>a. Potassium-sparing diuretics</label><br /><input type='radio' name='answer-796' id='answer-id-5792' class='answer' value='5792' /><label for='answer-id-5792'>b. Calcium-sparing diuretics</label><br /><input type='radio' name='answer-796' id='answer-id-5793' class='answer' value='5793' /><label for='answer-id-5793'>c. COX-2 inhibitors</label><br /><input type='radio' name='answer-796' id='answer-id-5794' class='answer' value='5794' /><label for='answer-id-5794'>d. Prostaglandin synthesis inhibitors</label><br /><input type='radio' name='answer-796' id='answer-id-5795' class='answer' value='5795' /><label for='answer-id-5795'>e. ACE inhibitors and/or AR blockers</label><br /></div><div class='question' id='question-3'><div class='question-content'>Which patient with a salt-losing tubulopathy is most likely at risk to develop end-stage renal failure later in life?</div><br /><input type='hidden' name='question_id[]' value='797' /><input type='radio' name='answer-797' id='answer-id-5800' class='answer' value='5800' /><label for='answer-id-5800'>a. Combined loop and DCT disorder with barttin defect (BS type IV)</label><br /><input type='radio' name='answer-797' id='answer-id-5801' class='answer' value='5801' /><label for='answer-id-5801'>b. Loop disorder with ROMK defect (BS type II)</label><br /><input type='radio' name='answer-797' id='answer-id-5802' class='answer' value='5802' /><label for='answer-id-5802'>c. DCT disorder with ClC-Kb defect (BS type III)</label><br /><input type='radio' name='answer-797' id='answer-id-5803' class='answer' value='5803' /><label for='answer-id-5803'>d. DCT disorder with NCCT defect (GS)</label><br /><input type='radio' name='answer-797' id='answer-id-5804' class='answer' value='5804' /><label for='answer-id-5804'>e. Loop disorder with NKCC2 defect (BS type I)</label><br /></div><div class='question' id='question-4'><div class='question-content'>Which special subtype of salt-losing tubulopathy is least likely to be associated with chronic hypercalciuria and nephrocalcinosis?</div><br /><input type='hidden' name='question_id[]' value='798' /><input type='radio' name='answer-798' id='answer-id-5805' class='answer' value='5805' /><label for='answer-id-5805'>a. NKCC2 defect (BS type I)</label><br /><input type='radio' name='answer-798' id='answer-id-5806' class='answer' value='5806' /><label for='answer-id-5806'>b. ClC-Kb defect (BS type III)</label><br /><input type='radio' name='answer-798' id='answer-id-5807' class='answer' value='5807' /><label for='answer-id-5807'>c. ROMK defect (BS type II)</label><br /><input type='radio' name='answer-798' id='answer-id-5808' class='answer' value='5808' /><label for='answer-id-5808'>d. Barttin defect (BS type IV)</label><br /></div><div class='question' id='question-5'><div class='question-content'>What is the most convenient way to differentiate between renal and extrarenal salt losses?</div><br /><input type='hidden' name='question_id[]' value='799' /><input type='radio' name='answer-799' id='answer-id-5809' class='answer' value='5809' /><label for='answer-id-5809'>a. Plasma electrolyte measurement</label><br /><input type='radio' name='answer-799' id='answer-id-5810' class='answer' value='5810' /><label for='answer-id-5810'>b. Urine osmolality</label><br /><input type='radio' name='answer-799' id='answer-id-5811' class='answer' value='5811' /><label for='answer-id-5811'>c. Urinary sodium and/or chloride levels</label><br /><input type='radio' name='answer-799' id='answer-id-5812' class='answer' value='5812' /><label for='answer-id-5812'>d. Sweat chloride test</label><br /></div><div class='question' id='question-6'><div class='question-content'>What is the most unlikely complication or sequelae of a DCT disorder with an apical uptake defect (GS)?</div><br /><input type='hidden' name='question_id[]' value='800' /><input type='radio' name='answer-800' id='answer-id-5817' class='answer' value='5817' /><label for='answer-id-5817'>a. Hypokalemic rhabdomyolysis</label><br /><input type='radio' name='answer-800' id='answer-id-5818' class='answer' value='5818' /><label for='answer-id-5818'>b. Nephrolithiasis</label><br /><input type='radio' name='answer-800' id='answer-id-5819' class='answer' value='5819' /><label for='answer-id-5819'>c. Growth retardation</label><br /><input type='radio' name='answer-800' id='answer-id-5820' class='answer' value='5820' /><label for='answer-id-5820'>d. Cardiac arrhythmias</label><br /><input type='radio' name='answer-800' id='answer-id-5821' class='answer' value='5821' /><label for='answer-id-5821'>e. Chondrocalcinosis 
 

</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="132" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2011/11/bartter-and-gitelman-like-syndromes-salt-losing-tubulopathies-with-loop-or-dct-defects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Rhabdomyolysis: pathogenesis of renal injury and management</title>
		<link>http://www.ipna-online.org/2011/11/rhabdomyolysis-pathogenesis-of-renal-injury-and-management/</link>
		<comments>http://www.ipna-online.org/2011/11/rhabdomyolysis-pathogenesis-of-renal-injury-and-management/#comments</comments>
		<pubDate>Thu, 10 Nov 2011 20:04:54 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Nephrology Emergencies]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1711</guid>
		<description><![CDATA[QUIZZIN 131]
]]></description>
			<content:encoded><![CDATA[<p>QUIZZIN 131]</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2011/11/rhabdomyolysis-pathogenesis-of-renal-injury-and-management/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Renal amyloidosis in children</title>
		<link>http://www.ipna-online.org/2011/11/renal-amyloidosis-in-children/</link>
		<comments>http://www.ipna-online.org/2011/11/renal-amyloidosis-in-children/#comments</comments>
		<pubDate>Thu, 10 Nov 2011 19:43:22 +0000</pubDate>
		<dc:creator>linda</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Chronic Kidney Disease]]></category>

		<guid isPermaLink="false">http://www.ipna-online.org/?p=1709</guid>
		<description><![CDATA[


The main cause of childhood amyloidosis isa. Juvenile idiopathic arthritisb. Beta2 microglobulin amyloidosisc. AFib amyloidosisd. Familial Mediterranean fevere. Familial cold autoinflammatory diseaseWhich of the answers below is wrong regarding  autoinflammatory diseases causing secondary amyloidosis in children?a. The mutations in the MEFV gene causing FMF are associated with excess Il-6 productionb. Colchicine is the mainstay treatment for the prevention [...]]]></description>
			<content:encoded><![CDATA[<p>
<div class="quiz-area single-page-quiz">
<form action="" method="post" class="quiz-form" id="quiz-130">
<div class='question' id='question-1'><div class='question-content'>The main cause of childhood amyloidosis is</div><br /><input type='hidden' name='question_id[]' value='785' /><input type='radio' name='answer-785' id='answer-id-5717' class='answer' value='5717' /><label for='answer-id-5717'>a. Juvenile idiopathic arthritis</label><br /><input type='radio' name='answer-785' id='answer-id-5718' class='answer' value='5718' /><label for='answer-id-5718'>b. Beta2 microglobulin amyloidosis</label><br /><input type='radio' name='answer-785' id='answer-id-5719' class='answer' value='5719' /><label for='answer-id-5719'>c. AFib amyloidosis</label><br /><input type='radio' name='answer-785' id='answer-id-5720' class='answer' value='5720' /><label for='answer-id-5720'>d. Familial Mediterranean fever</label><br /><input type='radio' name='answer-785' id='answer-id-5721' class='answer' value='5721' /><label for='answer-id-5721'>e. Familial cold autoinflammatory disease</label><br /></div><div class='question' id='question-2'><div class='question-content'>Which of the answers below is wrong regarding  autoinflammatory diseases causing secondary amyloidosis in children?</div><br /><input type='hidden' name='question_id[]' value='786' /><input type='radio' name='answer-786' id='answer-id-5726' class='answer' value='5726' /><label for='answer-id-5726'>a. The mutations in the MEFV gene causing FMF are associated with excess Il-6 production</label><br /><input type='radio' name='answer-786' id='answer-id-5727' class='answer' value='5727' /><label for='answer-id-5727'>b. Colchicine is the mainstay treatment for the prevention of amyloidosis in FMF</label><br /><input type='radio' name='answer-786' id='answer-id-5728' class='answer' value='5728' /><label for='answer-id-5728'>c. CAPS is associated with mutations in cryopyrin</label><br /><input type='radio' name='answer-786' id='answer-id-5729' class='answer' value='5729' /><label for='answer-id-5729'>d. Hematuria may be seen in FMF</label><br /><input type='radio' name='answer-786' id='answer-id-5730' class='answer' value='5730' /><label for='answer-id-5730'>e. Secondary amyloidosis may occur in TRAPS</label><br /></div><div class='question' id='question-3'><div class='question-content'>Which of the following is NOT associated with secondary amyloidosis in FMF?</div><br /><input type='hidden' name='question_id[]' value='787' /><input type='radio' name='answer-787' id='answer-id-5739' class='answer' value='5739' /><label for='answer-id-5739'>a. Male gender</label><br /><input type='radio' name='answer-787' id='answer-id-5740' class='answer' value='5740' /><label for='answer-id-5740'>b. Family history</label><br /><input type='radio' name='answer-787' id='answer-id-5741' class='answer' value='5741' /><label for='answer-id-5741'>c. SAA1.α/α genotype</label><br /><input type='radio' name='answer-787' id='answer-id-5742' class='answer' value='5742' /><label for='answer-id-5742'>d. Environment</label><br /><input type='radio' name='answer-787' id='answer-id-5743' class='answer' value='5743' /><label for='answer-id-5743'>e. E148Q homozygosity</label><br /></div><div class='question' id='question-4'><div class='question-content'>Which of the answers below  is WRONG about the treatment of amyloidosis?</div><br /><input type='hidden' name='question_id[]' value='788' /><input type='radio' name='answer-788' id='answer-id-5744' class='answer' value='5744' /><label for='answer-id-5744'>a. Colchicine is not effective in other causes of secondary amyloidosis</label><br /><input type='radio' name='answer-788' id='answer-id-5745' class='answer' value='5745' /><label for='answer-id-5745'>b. Eprodisate weakens the structural stability of amyloid fibrils</label><br /><input type='radio' name='answer-788' id='answer-id-5746' class='answer' value='5746' /><label for='answer-id-5746'>c. Hemodialysis and peritoneal dialysis appear to be equally effective</label><br /><input type='radio' name='answer-788' id='answer-id-5747' class='answer' value='5747' /><label for='answer-id-5747'>d. Colchicine should be continued in dialysis patients having FMF</label><br /><input type='radio' name='answer-788' id='answer-id-5748' class='answer' value='5748' /><label for='answer-id-5748'>e. Renal transplantation is the most effective treatment in Aβ2M amyloidosis </label><br /></div><div class='question' id='question-5'><div class='question-content'>What is the MOST common initial manifestation of renal disease secondary to amyloidosis?</div><br /><input type='hidden' name='question_id[]' value='789' /><input type='radio' name='answer-789' id='answer-id-5753' class='answer' value='5753' /><label for='answer-id-5753'>a. Hypertension</label><br /><input type='radio' name='answer-789' id='answer-id-5754' class='answer' value='5754' /><label for='answer-id-5754'>b. Asymptomatic hematuria</label><br /><input type='radio' name='answer-789' id='answer-id-5755' class='answer' value='5755' /><label for='answer-id-5755'>c. Asymptomatic proteinuria</label><br /><input type='radio' name='answer-789' id='answer-id-5756' class='answer' value='5756' /><label for='answer-id-5756'>d. Renal tubular acidosis</label><br /><input type='radio' name='answer-789' id='answer-id-5757' class='answer' value='5757' /><label for='answer-id-5757'>e. Chronic renal failure 
 

</label><br /></div><br />
<input type="button" id="next-question" value="Next &gt;"  /><br />

<input type="submit" name="action" id="action-button" value="Show Results"  />
<input type="hidden" name="quiz_id" value="130" />
</form>
</div>

</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ipna-online.org/2011/11/renal-amyloidosis-in-children/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

